Skip to main content
Equibles

Woodline Partners LP

Position in FATE — Fate Therapeutics Inc

CIK 1784547 San Francisco, CA
Back to FATE Full portfolio

Position in FATE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$431,055
+$144,675 QoQ
Shares Held
159,650
-33.1% QoQ
Ownership
0.133%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 156 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FATE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. FATE ranks #187 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 2,002,863 $375,096,182
2 PTGX
Protagonist Therapeutics, Inc
 1,414,173 $173,349,326
3 TNGX
Tango Therapeutics, Inc.
 4,000,567 $125,057,724
4 BHVN
Biohaven Ltd.
 7,660,280 $113,984,966
5 COGT
Cogent Biosciences, Inc.
 2,603,162 $100,742,369
6 CYTK
Cytokinetics Inc
 1,100,708 $93,769,314
7 RCUS
Arcus Biosciences, Inc.
 3,007,798 $92,730,412
8 ROIV
Roivant Sciences Ltd.
 2,500,673 $88,498,817

All Filings in FATE

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $431,055 159,650
2026-03-31 $286,380 238,650
2025-12-31 $349,517 356,650
2025-09-30 $897,939 712,650
2025-06-30 $798,168 712,650
2025-03-31 $1,125,091 1,424,167
2024-12-31 $2,347,595 1,422,785
2024-09-30 $10,730,114 3,065,747
2024-06-30 $3,286,566 1,002,002
2024-03-31 $13,887,294 1,892,002
2023-12-31 $1,441,261 385,364
2023-06-30 $476,266 100,056
2023-03-31 $570,022 100,004
2022-12-31 $1,621,644 160,718
2022-09-30 $3,601,690 160,718
2022-06-30 $3,982,592 160,718
2022-03-31 $6,231,036 160,718
2021-12-31 $11,647,936 199,076
2021-09-30 $9,065,761 152,957
2021-06-30 $11,378,689 131,106
2021-03-31 $10,418,382 126,360